Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
AstraZeneca
Merck
Boehringer Ingelheim
Baxter

Last Updated: November 14, 2019

DrugPatentWatch Database Preview

Mechanism of Action: Angiotensin 2 Receptor Antagonists

See Plans and Pricing

« Back to Dashboard

Drugs with Mechanism of Action: Angiotensin 2 Receptor Antagonists

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms AMLODIPINE AND OLMESARTAN MEDOXOMIL amlodipine besylate; olmesartan medoxomil TABLET;ORAL 207771-004 Sep 22, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Alkem Labs Ltd AMLODIPINE AND OLMESARTAN MEDOXOMIL amlodipine besylate; olmesartan medoxomil TABLET;ORAL 209042-002 Aug 14, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Macleods Pharms Ltd AMLODIPINE AND OLMESARTAN MEDOXOMIL amlodipine besylate; olmesartan medoxomil TABLET;ORAL 206884-003 Oct 26, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
Sciegen Pharms Inc AMLODIPINE AND OLMESARTAN MEDOXOMIL amlodipine besylate; olmesartan medoxomil TABLET;ORAL 209010-002 Dec 3, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Ajanta Pharma Ltd AMLODIPINE AND OLMESARTAN MEDOXOMIL amlodipine besylate; olmesartan medoxomil TABLET;ORAL 207216-002 Oct 28, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
Jubilant Generics AMLODIPINE AND OLMESARTAN MEDOXOMIL amlodipine besylate; olmesartan medoxomil TABLET;ORAL 207450-004 May 15, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Alkem Labs Ltd AMLODIPINE AND OLMESARTAN MEDOXOMIL amlodipine besylate; olmesartan medoxomil TABLET;ORAL 209042-003 Aug 14, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Boehringer Ingelheim
Baxter
Johnson and Johnson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.